These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31098699)

  • 1. [New drugs for treatment of juvenile idiopathic arthritis].
    Horneff G
    Z Rheumatol; 2019 Sep; 78(7):587-598. PubMed ID: 31098699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics in juvenile idiopathic arthritis: a narrative review.
    Vanoni F; Minoia F; Malattia C
    Eur J Pediatr; 2017 Sep; 176(9):1147-1153. PubMed ID: 28725955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates.
    Khawaja K; Al-Maini M
    Pediatr Rheumatol Online J; 2017 May; 15(1):41. PubMed ID: 28511684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biologics for treatment of juvenile idiopathic arthritis. Consensus statement of the 7th Wörlitzer Expertengespräche 2004 for the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie].
    Horneff G
    Z Rheumatol; 2006 Mar; 65(2):152-6, 158. PubMed ID: 16372138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in Pediatric Rheumatology: Quo Vadis?
    Sterba Y; Ilowite N
    Curr Rheumatol Rep; 2016 Jul; 18(7):45. PubMed ID: 27306623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
    Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
    Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.
    Janow G; Schanberg LE; Setoguchi S; Hasselblad V; Mellins ED; Schneider R; Kimura Y;
    J Rheumatol; 2016 Sep; 43(9):1755-62. PubMed ID: 27307527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel treatment options for juvenile idiopathic arthritis.
    Steigerwald KA; Ilowite NT
    Expert Rev Clin Pharmacol; 2015; 8(5):559-73. PubMed ID: 26294075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].
    Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M;
    Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacosurveillance in Juvenile Idiopathic Arthritis.
    Shiff NJ; Beukelman T
    Rheum Dis Clin North Am; 2021 Nov; 47(4):643-653. PubMed ID: 34635296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].
    Niewerth M; Minden K; Klotsche J; Horneff G
    Z Rheumatol; 2014 Aug; 73(6):532-40. PubMed ID: 25096586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: a systematic review.
    Ungar WJ; Costa V; Burnett HF; Feldman BM; Laxer RM
    Semin Arthritis Rheum; 2013 Jun; 42(6):597-618. PubMed ID: 23337074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile idiopathic arthritis in the new world of biologics.
    Ostring GT; Singh-Grewal D
    J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.
    Cellucci T; Guzman J; Petty RE; Batthish M; Benseler SM; Ellsworth JE; Houghton KM; LeBLANC CM; Huber AM; Luca N; Schmeling H; Shiff NJ; Soon GS; Tse SM;
    J Rheumatol; 2016 Oct; 43(10):1773-1776. PubMed ID: 27698103
    [No Abstract]   [Full Text] [Related]  

  • 15. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.
    Ringold S; Weiss PF; Beukelman T; DeWitt EM; Ilowite NT; Kimura Y; Laxer RM; Lovell DJ; Nigrovic PA; Robinson AB; Vehe RK;
    Arthritis Rheum; 2013 Oct; 65(10):2499-512. PubMed ID: 24092554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis.
    Baris HE; Anderson E; Sozeri B; Dedeoglu F
    Clin Rheumatol; 2018 Dec; 37(12):3263-3273. PubMed ID: 30238379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological disease-modifying antirheumatic drugs in juvenile idiopathic arthritis of polyarticular course, enthesitis-related arthritis, and psoriatic arthritis: a consensus statement.
    Ho ACH; Wong SN; Leung LCK; Chan WKY; Chong PCY; Tse NKC; Yeung RHM; Kong SY; Lee KP
    Hong Kong Med J; 2020 Feb; 26(1):56-65. PubMed ID: 32077861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.
    Horneff G; Schulz AC; Klotsche J; Hospach A; Minden K; Foeldvari I; Trauzeddel R; Ganser G; Weller-Heinemann F; Haas JP
    Arthritis Res Ther; 2017 Nov; 19(1):256. PubMed ID: 29166924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging biologics for the treatment of juvenile idiopathic arthritis.
    Cimaz R; Maioli G; Calabrese G
    Expert Opin Biol Ther; 2020 Jul; 20(7):725-740. PubMed ID: 32116038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
    Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
    Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.